Smart + Strong.
All Rights Reserved.
Smart + Strong®
is a registered trademark of CDM Publishing, LLC.
The process toward a creating a healthier lifestyle and discovering my genotype.
Major clinical trials of hepatitis C drugs among those with HIV had very restrictive eligibility, questioning their generalizability.
Sofosbuvir and ribavirin cured between 67 and 88 percent of those coinfected with HIV and genotypes 1, 2 or 3 of hepatitis C virus.
The hepatitis C pipeline: huge changes on the horizon
Although hepatitis C virus (HCV) is a common and serious coinfection among people living with HIV, it often goes undiagnosed, even in a major...
New data suggest about two in 10 individuals diagnosed with HIV in recent years were infected with HIV strains harboring mutations.
Drug-resistance testing is recommended at the time of HIV infection diagnosis, as well as in all cases of treatment failure, reiterate new gui...
New method for interpreting the results of predictive phenotype test better predicts actual responses to treatment than an older method.
You have been inactive for 60 minutes and will be logged out in . Any updates not saved will be lost.
Click here to log back in.